Bio-Rad Laboratories | BIO - Gewinn Vor Steuern

Aktienkurs
279.72
Täglich Wechseln
4.57 1.66%
Monatlich
0.35%
Jährlich
16.58%
Q2 Prognose
281.68




Gewinn Vor Steuern Veränderung Datum
Abbott USD 2.39B 27M 2026-03
Agilent USD 442M 1000K 2025-09
Becton, Dickinson and Co. USD 393M 117M 2025-12
Bio Techne USD 84.99M 107.85M 2025-09
Bio-Rad Laboratories USD 929.2M 846.3M 2025-12
Bruker USD -72.6M 73.1M 2025-09
Charles River Laboratories USD 170.03M 98.62M 2025-09
Danaher USD 1.24B 138M 2026-03
General Electric Aerospace USD 2.2B 654M 2026-03
Illumina USD 377M 157M 2025-12
IQVIA Holdings USD 537M 5.62B 2025-12
Laboratory Of America USD 190.6M 146.4M 2025-12
Merck USD 3.42B 3.32B 2025-12
Mettler Toledo International USD 269.24M 20.58M 2025-09
Myriad Genetics USD 4.6M 3.4M 2025-12
OraSure Technologies USD -18.43M 5.14M 2025-12
Pacific Biosciences Of California USD -40.17M 2.55M 2025-12
Quest Diagnostics USD 334M 4M 2026-03
Repligen USD 17.11M 10.25M 2025-09
Revvity USD 55.68M 115.97M 2025-09
Roche Holding CHF 4.79B 3.01B 2025-06
Siemens EUR 2.39B 505M 2025-09
Standard Biotools USD -22.03M 10.87M 2025-12
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Tosoh JPY 30.93B 18.15B 2025-12
Waters USD 170.12M 7.57M 2025-09